Increasing AML clinical trial participation rates

Despite major advancements in the understanding of the genetic drivers of acute myeloid leukemia (AML) and the pathophysiology of the disease, standard treatment options for AML patients have not expe... Author: VJHemOnc Added: 05/29/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts